Showcases Outstanding Innovation Driving Improvements and Transforming the Industries
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Questex's Fierce Healthcare, Fierce Biotech and Fierce Pharma today announce the finalists of the Fierce Healthcare Innovation Awards and the Fierce Life Sciences Innovation Awards. Both awards programs showcase outstanding innovation that is driving improvements and transforming the healthcare and life sciences industries.
"We are thrilled to announce the 2024 finalists in healthcare and life sciences,” said Rebecca Willumson, Senior Vice President & Publisher, Fierce Life Sciences and Healthcare. "As we reviewed the submissions we saw the power of innovation - how these companies dared to think differently and create something new. We applaud the finalists on their commitment to innovation. We look forward to seeing who comes out on top later this year.”
The Healthcare Innovation Awards finalists are:
Artificial Intelligence Solutions
- AKASA GenAI-Powered Revenue Cycle Solutions; AKASA
- ArteraAI Prostate Test; Artera
- CaRi-Heart ® Technology; Caristo Diagnostics
- Phoenix; Sword Health
- Volta AF-Xplorer™Volta, Medical
- Avo
- DecisionRx Medication Therapy Optimization (MTO) platform; DecisionRx, Inc.
- Elaborate Inbasket Platform; Elaborate
- Hixny's Snapshot; Hixny
- Optain Resolve; Optain
- DSO Analytics; Overjet
- Freshpaint
- Innovaccer's Data Activation Platform; Innovaccer Inc.
- MDaudit
- MDClone ADAMS platform; MDClone
- BioIntelliSense BioButton medical-grade wearable for continuous vital sign monitoring from in-hospital to home; BioIntelliSense, Inc.
- Cionic Neural Sleeve; CIONIC
- Foodsmart
- Outcomes4Me Cancer Care; Outcomes4Me Inc.
- Xealth Digital Health Platform; Xealth
- CR NoteGuardAI; CentralReach
- Edifecs Healthcare Interoperability Cloud; Edifecs
- HSBlox CureAlign® Platform; HSBlox
- RE Assist; Real Endpoints
- Zelis Health Bill Assist; Zelis
- Carrum Health
- FarmboxRx
- Innovaccer's Care Management Solution; Innovaccer Inc.
- p2FA Connect; Nucleotrace
- Zio® ECG monitoring service; iRhythm Technologies, Inc.
AI Innovation
- AI-based pathology; BostonGene
- Apollo Intelligence Next-Generation Platform for Market Insights; Apollo Intelligence
- EMLy; Etcembly Ltd
- Genialis™ krasID; Genialis
- Coya Therapeutics, COYA 302; Coya Therapeutics
- Fridge-free Vaccine & Pharmaceutical Technology; Stablepharma Ltd
- NeuroKaire
- Ohtuvayre (ensifentrine); Verona Pharma
- EncompaaS Rebate Management; EncompaaS
- Patient timeline from unstructured data; BostonGene
- The DNAnexus-built Research Analysis Platform for UK Biobank; DNAnexus
- Truveta Language Model; Truveta
- juli; juliInc.
- NOWINCLUDED Powered by Acclinate; Acclinate
- Viz HCM™; Viz.ai, Inc.
- Zio® ECG monitoring service; iRhythm Technologies, Inc.
- Retargeted Antibody AAV Platform; Regeneron
- COUR Nanoparticle Platform; COUR Pharmaceuticals
- enFuse Wearable Drug Delivery System; Enable Injections
- Nasdepi; Belhaven Biopharma
- MiniMed 780G system; Medtronic
- RefleXion® X1 with SCINTIX® biology-guided radiotherapy; RefleXion Medical
- Symani Surgical System; MMI (Medical Microinstruments)
- Tandem Mobi; Tandem Diabetes Care
- Terran Biosciences' NM-101; Terran Biosciences
- Vibrant; Vibrant Gastro
- ASCEND; BenchSci
- Cellares Cell Shuttle + Cell Q; Cellares
- Luminopia; Luminopia, Inc.
- OcuLenz AR for individuals with AMD; Ocutrx Technologies, Inc.
Award winners will be announced on December 2, 2024.
About Questex
Questex helps people live better and longer. Questex brings people together in the markets that help people live better: travel, hospitality and wellness; the industries that help people live longer: life science and healthcare; and the technologies that enable and fuel these new experiences. We live in the experience economy - connecting our ecosystem through live events, surrounded by data insights and digital communities. We deliver experience and real results. It happens here.
Media Contact
Linda Lam
Director of Marketing, Life Sciences and Healthcare
